Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

75.46 -0.35 (-0.46%)
Streaming Delayed Price Updated: 12:38 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 489,131
Open 75.77
Bid (Size) 75.45 (1)
Ask (Size) 75.47 (1)
Prev. Close 75.81
Today's Range 75.32 - 76.02
52wk Range 42.01 - 77.59
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Halozyme Therapeutics Inc (NASDAQ:HALO) Embodies Navellier's Growth Investing Principles
Discover Halozyme (HALO), a top growth stock with strong earnings surprises, soaring revenue, and exceptional profitability, fitting Navellier's proven investment strategy. 
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Case for Value Investors
Halozyme (HALO) presents a strong value investing case with low P/E ratios, robust financial health, high profitability, and solid growth, suggesting it trades below its intrinsic value. 
Via Chartmill

Performance

YTD
+57.2%
+57.2%
1 Month
+9.4%
+9.4%
3 Month
+42.0%
+42.0%
6 Month
+17.4%
+17.4%
1 Year
+21.8%
+21.8%

More News

Read More
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
Via Investor's Business Daily
Topics ETFs
Halozyme Therapeutics Inc (NASDAQ:HALO) Fits Minervini's Trend Template with Strong Technicals and Earnings Momentum
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Offers Affordable Growth With Strong Fundamentals
Via Chartmill
Earnings Scheduled For August 5, 2025
Via Benzinga
Earnings Outlook For Halozyme Therapeutics
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Stands Out in Navellier's Growth Screen
Via Chartmill
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
Via Investor's Business Daily
Topics ETFs
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Stands Out as a Top Undervalued Stock with Strong Fundamentals
Via Chartmill
What 7 Analyst Ratings Have To Say About Halozyme Therapeutics
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Top Pick for Affordable Growth Investors
Via Chartmill
What Does the Market Think About Halozyme Therapeutics?
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Fits Louis Navellier’s High-Growth Stock Criteria
Via Chartmill
Halozyme (HALO) Q2 EPS Jumps 69%
Via The Motley Fool
Topics Intellectual Property
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Shows Strong Growth Momentum and Technical Breakout Potential
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Stands Out as a Strong Undervalued Stock with Solid Fundamentals
Via Chartmill
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - A Strong Contender in Affordable Growth Stocks
Via Chartmill
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - A Strong Candidate for Affordable Growth Investors
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Biotech Stock With Strong Fundamentals and Attractive Valuation
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
Here's How Much $100 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth Today
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - A Strong Candidate for Affordable Growth Investors
Via Chartmill

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 75.46
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 09/18/25 12:38 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 10.74B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.